Most Popular

1
IMF lowers Korea's 2025 growth outlook to 2%
2
Labor Ministry dismisses Hanni harassment case
3
Reality show 'I Live Alone' disciplined for 'glorifying' alcohol consumption
4
North Korean troops fighting alongside Russia, NIS confirms
5
Now is no time to add pressure on businesses: top executives

6
CJ CheilJedang to spur overseas growth with new Hungary, US plants
7
Japan to hold 1st memorial for Korean forced labor victims at Sado mine
8
[Herald Interview] How Gopizza got big in India
9
[KH Explains] Dissecting Hyundai Motor's lobbying in US
10
Nearly half of pines at Seoraksan face extinction due to global warming: study

NewsletterSubscribe

Start your day with a roundup of key stories from The Korea Herald with news and comment on all that’s happening in Korea.

Ahngook Pharma’s cough syrup to be sold in C. America

By 황유미

Published : Oct. 12, 2016 - 13:52

- Link copied

[THE INVESTOR] Ahngook Pharmaceutical announced on Oct. 12 that it has signed an agreement with multinational pharmaceutical company Menarini for sales rights of its cough syrup Synatura in seven Central American countries.

The Italy-based company will have sales and marketing rights of the cough and mucus reducer in Guatemala, Honduras, El Salvador, Nicaragua, Costa Rica, Panama and Belize. The contract amount remains undisclosed.

Synatura Syrup was introduced in 2011 by the South Korean firm.

By Hwang You-mee (glamazon@heraldcorp.com)

Ahngook Pharma’s cough syrup to be sold in C. America

More from Headlines